DDIT3（12q13）基因斷裂探針
| 型 號(hào)： | |
| 報(bào) 價(jià)： |  |
DDIT3（12q13）基因斷裂探針 ERG是母紅血球病病毒E26轉(zhuǎn)換序列（ETS）轉(zhuǎn)錄因子的基因家族成員之一，它在淋巴細(xì)胞和內(nèi)皮細(xì)胞表達(dá)，調(diào)節(jié)內(nèi)皮細(xì)胞凋亡和血管生成。研究發(fā)現(xiàn)ERG在良性和惡性的血管腫瘤都有表達(dá)。用于檢測(cè)甲狀腺濾泡癌常見的PPARγ基因斷裂及與其他基因的易位。 本試劑盒僅供科研使用。
- 產(chǎn)品描述
DDIT3（12q13）基因斷裂探針
廣州健侖生物科技?有限公司
本司長(zhǎng)期供應(yīng)尼古丁（可替寧）檢測(cè)試劑盒，其主要品牌包括美國(guó)NovaBios、廣州健侖、廣州創(chuàng)侖等進(jìn)口產(chǎn)品，國(guó)產(chǎn)產(chǎn)品，試劑盒的實(shí)驗(yàn)方法是膠體金方法。
我司還有很多熒光原位雜交系列檢測(cè)試劑盒以及各種FISH基因探針和染色體探針等，。
DDIT3（12q13）基因斷裂探針
用于檢測(cè)DDIT3（12q13）基因斷裂的情況。
本試劑盒僅供科研使用。
歡迎咨詢
歡迎咨詢
以下是我司出售的部分FISH產(chǎn)品：
| FOXR2(Xp11)基因斷裂探針 |
| 6q27(MLLT4)檢測(cè)探針 |
| NUT(15q14)檢測(cè)探針 |
| CDKN2A（9p21）基因探針（含9號(hào)著絲粒） |
| EWSR1/WT1融合基因t (11;22)探針 |
| [BCR/ABL(DF)]/ASS探針 |
| [BCRABL(DF)]/[ETV6/RUNX1]/KMT2A/IGH探針 |
| [PML/RARA]/CBFB/[AML1/ETO]/KMT2A探針 |
| ATM/p53/13q14/RB1/CSP12探針 |
| BCL6/MYC/[CCND1/IGH]/[BCL2/IGH]探針 |
| 20q/+8/[-7/-7q]/[-5/-5q]/-Y探針 |
| CDK4（12q14）基因擴(kuò)增探針 |
| WWTR1/CAMTA1融合基因t (1;3)探針 |
| MGEA5（10q24）基因斷裂探針 |
| D13S319基因探針（紅色） |
| HMGA2（12q14）基因斷裂探針 |
| MYB/NFIB融合基因t(6;9)探針 |
| FOSB（19q13）基因斷裂探針 |
我司還提供：登革熱，黃熱病，基肯孔熱，西尼羅河，立次克體，無形體，蜱蟲，恙蟲，錐蟲，利什曼原蟲，RK39, 漢坦病毒，乙腦，森林腦炎，寨卡病毒 ，H7N9 ,流感，霍亂，軍團(tuán)菌，結(jié)核，諾如病毒，輪狀病毒，炭疽，O157，葡萄球菌 ，流行性出血熱，傷寒桿菌，志賀氏菌檢測(cè)試劑,！
二維碼掃一掃
【公司名稱】 廣州健侖生物科技有限公司
【】 楊永漢
【】
【騰訊 】
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化宣傳】
After 6 years of exploration, Shanghai experts found genetic characteristics and genetic background of China patients with esophageal squamous cell carcinoma, and for the first time that an important cause of such China Asian population at high risk of esophageal squamous cell carcinoma NFE2L2 gene "germline mutation" risk higher than others.
In January 4th, reporters from the Tumour Hospital Affiliated to Fudan University (www.thepaper。。ｃｎ) received the news from Tumour Hospital Affiliated to Fudan University. The research results are also published online in the Nature Communications, a sub issue of the international authoritative journal Nature.
Find the "culprit" in the difference of genetic map
China is a country with high incidence of esophageal cancer. The number of cases is 50% of the world, of which 90% is squamous cell carcinoma. In the United States, the incidence of esophageal cancer is low, and the pathological type is mainly adenocarcinoma.
In addition to the effects of living habits and carcinogens, what are the reasons for the incidence and pathological types of esophageal cancer, with such a large demographic difference?
Professor Zhao Kuaile tried to analyze the genetic material DNA in human cells from the source, and then explore the genetic difference of esophageal cancer in different races. "If we can find the pathogenesis of esophageal cancer from the gene level, we will provide a new strategy basis for the prevention and treatment of esophageal cancer for Chinese race," Zhao Kuaile said.
